title: Blockade of angiotensin II AT 1 receptor reduces hematocrit in patients with posttransplant erythrocytosis.
authors.affiliation: Department of Medicine, Princess Margaret Hospital, Hong Kong, China.
authors.forename: W K
authors.initials: WK
authors.lastname: Tsang
authors.forename: K L
authors.initials: KL
authors.lastname: Tong
authors.forename: H W
authors.initials: HW
authors.lastname: Chan
mesh_terms: D000328:Adult; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D006400:Hematocrit; D006801:Humans; D016030:Kidney Transplantation; D019808:Losartan / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D011086:Polycythemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D011183:Postoperative Complications; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2
chemical_list: D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D019808:Losartan